Meeder Asset Management Inc Immuno Gen, Inc. Transaction History

Meeder Asset Management Inc

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 08, 2021	SELL	$5.02 - $6.59 $441 - $579	-88 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$5.79 - $8.6 $509 - $756	88 New	88 $1,000
Q4 2020 Feb 09, 2021	SELL	$3.7 - $7.66 $20,198 - $41,815	-5,459 Closed	0 $0
Q3 2020 Nov 02, 2020	SELL	$3.45 - $4.89 $24,412 - $34,601	-7,076 Reduced 56.45%	5,459 $19,000
Q2 2020 Aug 11, 2020	BUY	$3.32 - $5.34 $18,844 - $30,309	5,676 Added 82.75%	12,535 $58,000
Q1 2020 May 15, 2020	SELL	$2.12 - $6.8 $17,420 - $55,875	-8,217 Reduced 54.5%	6,859 $21,000
Q4 2019 Feb 13, 2020	BUY	$2.25 - $5.8 $18,821 - $48,517	8,365 Added 124.65%	15,076 $78,000
Q3 2019 Oct 17, 2019	BUY	$2.22 - $3.39 $13,379 - $20,431	6,027 Added 881.14%	6,711 $16,000
Q2 2019 Aug 05, 2019	BUY	$1.8 - $3.3 $1,231 - $2,257	684 New	684 $1,000
Q1 2019 Apr 16, 2019	SELL	$2.41 - $5.91 $2,262 - $5,549	-939 Closed	0 $0
Q4 2018 Jan 17, 2019	SELL	$3.94 - $9.7 $1,178 - $2,900	-299 Reduced 24.15%	939 $5,000
Q3 2018 Nov 02, 2018	SELL	$8.6 - $11.26 $20,072 - $26,280	-2,334 Reduced 65.34%	1,238 $0
Q2 2018 Jul 24, 2018	BUY	$9.52 - $12.15 $11,957 - $15,260	1,256 Added 54.23%	3,572 $0
Q1 2018 May 03, 2018	BUY	$6.7 - $12.95 $15,316 - $29,603	2,286 Added 7620.0%	2,316 $25,000
Q4 2017 Feb 02, 2018	SELL	$5.07 - $7.92 $2,053 - $3,207	-405 Reduced 93.1%	30 $0
Q3 2017 Oct 20, 2017	BUY	$5.4 - $8.47 $2,349 - $3,684	435	435 $3,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.